Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Sensation Disorders D012678 2 associated lipids
Ileus D045823 3 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Onions VJ et al. Ovarian tissue viability following whole ovine ovary cryopreservation: assessing the effects of sphingosine-1-phosphate inclusion. 2008 Hum. Reprod. pmid:18216042
Hannun YA and Obeid LM Principles of bioactive lipid signalling: lessons from sphingolipids. 2008 Nat. Rev. Mol. Cell Biol. pmid:18216770
Wymann MP and Schneiter R Lipid signalling in disease. 2008 Nat. Rev. Mol. Cell Biol. pmid:18216772
Schüppel M et al. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. 2008 J. Invest. Dermatol. pmid:18219276
Tan W et al. An essential role for Rac1 in endothelial cell function and vascular development. 2008 FASEB J. pmid:18245172
Wang L et al. Rho GTPases mediated integrin alpha v beta 3 activation in sphingosine-1-phosphate stimulated chemotaxis of endothelial cells. 2008 Histochem. Cell Biol. pmid:18247041
Venkataraman K et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. 2008 Circ. Res. pmid:18258856
Leclercq TM et al. Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity. 2008 J. Biol. Chem. pmid:18263879
Moriue T et al. Sphingosine 1-phosphate attenuates H2O2-induced apoptosis in endothelial cells. 2008 Biochem. Biophys. Res. Commun. pmid:18267109
Fortier S et al. Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells. 2008 FEBS Lett. pmid:18267120
Jiang H et al. Distinguishing fibroblast promigratory and procontractile growth factor environments in 3-D collagen matrices. 2008 FASEB J. pmid:18272655
Sobue S et al. Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells. 2008 Int. J. Hematol. pmid:18283525
Alford SK et al. Endothelial cell migration in human plasma is enhanced by a narrow range of added sphingosine 1-phosphate: implications for biomaterials design. 2009 J Biomed Mater Res A pmid:18286622
Pasquaré SJ et al. Involvement of lysophosphatidic acid, sphingosine 1-phosphate and ceramide 1-phosphate in the metabolization of phosphatidic acid by lipid phosphate phosphatases in bovine rod outer segments. 2008 Neurochem. Res. pmid:18288612
Kunisawa J et al. Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells. 2008 Blood pmid:18292290
Sabourdy F et al. Functions of sphingolipid metabolism in mammals--lessons from genetic defects. 2008 Biochim. Biophys. Acta pmid:18294974
Gorshkova I et al. Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1. 2008 J. Biol. Chem. pmid:18296444
Means CK et al. S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses. 2008 J. Biol. Chem. pmid:18296752
Dyatlovitskaya EV Sphingolipid receptors. 2008 Biochemistry Mosc. pmid:18298366
Won J and Lee GH T-cell-targeted signaling inhibitors. 2008 Jan-Apr Int. Rev. Immunol. pmid:18300054
Sensken SC et al. Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate. 2008 Cell. Signal. pmid:18313900
Kim HL et al. Characterization of N,N,-dimethyl-D-erythro-sphingosine-induced apoptosis and signaling in U937 cells: independence of sphingosine kinase inhibition. 2008 Prostaglandins Other Lipid Mediat. pmid:18316219
Valentine WJ et al. Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors. 2008 J. Biol. Chem. pmid:18316373
Huwiler A and Pfeilschifter J New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets. 2008 Biochem. Pharmacol. pmid:18321471
Jo SK et al. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. 2008 Kidney Int. pmid:18322542
Hughes JE et al. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. 2008 Circ. Res. pmid:18323526
Provençal M et al. Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins. 2008 Thromb. Haemost. pmid:18327407
Beyer T and Meyer-Hermann M Mechanisms of organogenesis of primary lymphoid follicles. 2008 Int. Immunol. pmid:18334502
Park HY et al. K6PC-5, a novel sphingosine kinase activator, improves long-term ultraviolet light-exposed aged murine skin. 2008 Exp. Dermatol. pmid:18341573
Nishiuma T et al. Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. 2008 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:18359884
Gude DR et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. 2008 FASEB J. pmid:18362204
Liu HB et al. Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis. 2008 Pancreas pmid:18362832
Yatomi Y [Physiologically active substances derived from activated platelets: overview in clinical medicine]. 2008 Nippon Naika Gakkai Zasshi pmid:18363212
Gavrilovskaya IN et al. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. 2008 J. Virol. pmid:18367532
Hashimoto M et al. Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor. 2008 Am. J. Respir. Cell Mol. Biol. pmid:18367729
Igarashi J and Michel T The enigma of sphingosine 1-phosphate synthesis: a novel role for endothelial sphingosine kinases. 2008 Circ. Res. pmid:18369161
Goetzl EJ et al. Regulation of the roles of sphingosine 1-phosphate and its type 1 G protein-coupled receptor in T cell immunity and autoimmunity. 2008 Biochim. Biophys. Acta pmid:18381082
Hong JH et al. K6PC-5, a direct activator of sphingosine kinase 1, promotes epidermal differentiation through intracellular Ca2+ signaling. 2008 J. Invest. Dermatol. pmid:18385762
Lebman DA and Spiegel S Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. 2008 J. Lipid Res. pmid:18387885
Ryan JJ and Spiegel S The role of sphingosine-1-phosphate and its receptors in asthma. 2008 Drug News Perspect. pmid:18389100
Gohda M et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses. 2008 J. Immunol. pmid:18390715
Avery K et al. Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. 2008 Stem Cells Dev. pmid:18393631
Eskan MA et al. TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. 2008 Eur. J. Immunol. pmid:18395849
Krump-Konvalinkova V et al. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression. 2008 Biochem. Biophys. Res. Commun. pmid:18402775
Olivera A Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model. 2008 Prostaglandins Other Lipid Mediat. pmid:18403224
Sefcik LS et al. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. 2008 Biomaterials pmid:18405965
Arce FT et al. Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin. 2008 Biophys. J. pmid:18408039
Dueñas AI et al. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. 2008 Cardiovasc. Res. pmid:18411230
Vessey DA et al. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate. 2008 Mar-Apr J. Biochem. Mol. Toxicol. pmid:18418901
Youm JK et al. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling. 2008 J. Dermatol. Sci. pmid:18420384
Li QF et al. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. 2008 Biochem. Biophys. Res. Commun. pmid:18423379
Wu YP et al. Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease. 2008 Hum. Mol. Genet. pmid:18424450
Lavieu G et al. Sphingolipids in macroautophagy. 2008 Methods Mol. Biol. pmid:18425450
Miller AV et al. Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. 2008 Mol. Cell. Biol. pmid:18426913
Löf C et al. Overexpression of TRPC3 reduces the content of intracellular calcium stores in HEK-293 cells. 2008 J. Cell. Physiol. pmid:18431718
Rapizzi E et al. Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts. 2008 Mol. Cell. Biochem. pmid:18454302
Murakami M et al. Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. 2008 Biochem. Biophys. Res. Commun. pmid:18466763
Takuwa Y et al. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. 2008 Biochim. Biophys. Acta pmid:18472021
Takashima S et al. G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. 2008 Cardiovasc. Res. pmid:18480127
Rivera R and Chun J Biological effects of lysophospholipids. 2008 Rev. Physiol. Biochem. Pharmacol. pmid:18481029
Bu S et al. Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway. 2008 J. Biol. Chem. pmid:18482992
Tölle M et al. HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. 2008 Arterioscler. Thromb. Vasc. Biol. pmid:18483405
Huang YT et al. Sphingosine 1-phosphate induces platelet/endothelial cell adhesion molecule-1 phosphorylation in human endothelial cells through cSrc and Fyn. 2008 Cell. Signal. pmid:18502612
Chen LY et al. Cytosolic phospholipase A2alpha activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells. 2008 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:18502815
Rivera-Lopez CM et al. Lysophosphatidic acid (LPA) and angiogenesis. 2008 Angiogenesis pmid:18504643
Balthasar S et al. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. 2008 Endocr. Relat. Cancer pmid:18509004
Kohno T and Igarashi Y Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P. 2008 Genes Cells pmid:18513330
Devine KM et al. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. 2008 Gynecol. Oncol. pmid:18513786
Jin YZ et al. Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease. 2008 Eur. J. Immunol. pmid:18521956
Wamhoff BR et al. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. 2008 Arterioscler. Thromb. Vasc. Biol. pmid:18535287
Yoon CM et al. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. 2008 Blood pmid:18541717
He X et al. Deregulation of sphingolipid metabolism in Alzheimer's disease. 2010 Neurobiol. Aging pmid:18547682
Takabe K et al. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. 2008 Pharmacol. Rev. pmid:18552276
Facchinetti MM et al. Stratification of sphingosine kinase-1 expression and activity in rat kidney. 2008 Cells Tissues Organs (Print) pmid:18552482
Kihara A and Igarashi Y Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. 2008 Biochim. Biophys. Acta pmid:18555808
Worrall D et al. Involvement of sphingosine kinase in plant cell signalling. 2008 Plant J. pmid:18557834
Pyne NJ and Pyne S Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination. 2008 Biochim. Biophys. Acta pmid:18558100
Heller R et al. Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. 2008 Cardiovasc. Res. pmid:18558630
Limaye V The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology. 2008 May-Jun Endothelium pmid:18568950
Son DJ et al. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. 2008 Prostaglandins Leukot. Essent. Fatty Acids pmid:18571912
Ohkawa R et al. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. 2008 Ann. Clin. Biochem. pmid:18583619
Peavy RD and Metcalfe DD Understanding the mechanisms of anaphylaxis. 2008 Curr Opin Allergy Clin Immunol pmid:18596587
Cheon S et al. Sphingosine kinase inhibitor suppresses IL-18-induced interferon-gamma production through inhibition of p38 MAPK activation in human NK cells. 2008 Biochem. Biophys. Res. Commun. pmid:18602364
Argraves KM et al. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. 2008 J. Biol. Chem. pmid:18606817
González-Díez M et al. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. 2008 Thromb. Haemost. pmid:18612546
Lynch KR and Macdonald TL Sphingosine 1-phosphate chemical biology. 2008 Biochim. Biophys. Acta pmid:18638568
Igarashi J and Michel T S1P and eNOS regulation. 2008 Biochim. Biophys. Acta pmid:18638569
Machesky NJ et al. Human cytomegalovirus regulates bioactive sphingolipids. 2008 J. Biol. Chem. pmid:18644793
Pchejetski D et al. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. 2008 Mol. Cancer Ther. pmid:18644996
Wang D et al. S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. 2008 Mol. Cancer Ther. pmid:18645009
Greenspon J et al. Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway. 2009 Dig. Dis. Sci. pmid:18654850
Zhao C et al. Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha. 2008 J. Lipid Res. pmid:18658144
Levkau B Sphingosine-1-phosphate in the regulation of vascular tone: a finely tuned integration system of S1P sources, receptors, and vascular responsiveness. 2008 Circ. Res. pmid:18669929
Bollag WB Potential role of sphingosine 1-phosphate in the pathogenesis of rheumatoid arthritis. 2008 J. Lipid Res. pmid:18669980
Hla T et al. The vascular S1P gradient-cellular sources and biological significance. 2008 Biochim. Biophys. Acta pmid:18674637
Kono M et al. Sphingosine-1-phosphate regulation of mammalian development. 2008 Biochim. Biophys. Acta pmid:18675379
Tanaka R et al. Cell-culture-dependent change of Ca2+ response of rat aortic myocytes to sphingosine-1-phosphate. 2008 J. Pharmacol. Sci. pmid:18678983
Alvero AB et al. Anti-tumor activity of phenoxodiol: from bench to clinic. 2008 Future Oncol pmid:18684059
Swaney JS et al. Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. 2008 Exp. Eye Res. pmid:18687328
Zeidan YH et al. Molecular targeting of acid ceramidase: implications to cancer therapy. 2008 Curr Drug Targets pmid:18691012